Masimo Corporation

Valuation Analysis

About the Company

Masimo Corporation en bref

Masimo Corporation (MASI) is currently trading at 157,04 € with a market capitalization of 8,2 Md €. The trailing P/E ratio stands at 44.43x, with a forward P/E of 26.84x. The 52-week range spans from 109,90 € to 157,07 €; the current price is 0% below the yearly high. Year-over-year revenue growth stands at +8.5%. The net profit margin stands at 4.9%.

💰 Dividende

Masimo Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

3 analystes évaluent Masimo Corporation (MASI) au consensus : Conserver. L'objectif de cours moyen est de 157,08 €, soit un potentiel de +0.03% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 157,08 € à 157,08 €.

Masimo Corporation : la thèse d'investissement en détail

Masimo Corporation (MASI) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 61.63%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Le scénario baissier

With a net margin of just 4.9%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

At a PEG of 4.83, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here. The EV/EBITDA multiple of 26.61x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

À surveiller

• The forward P/E of 26.84x is meaningfully below the trailing 44.43x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 99.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to market-like volatility, elevated short interest (7.34%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Masimo Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.